health
Trump’s Ibogaine Executive Order Is a Big Step to Solve Generational Threat
President Donald Trump recently signed an executive order encouraging research on the psychedelic ibogaine as a possible treatment for mental health challenges such as substance use disorder, depression, and post-traumatic stress disorder. This comes on the heels of over 220 psychedelic policy reform bills that have been introduced in the states over the last five years.
TL;DR
- President Trump signed an executive order promoting research on the psychedelic ibogaine for mental health issues.
- This follows over 220 psychedelic policy reform bills introduced in states over the past five years.
- The author, a Republican legislator, successfully passed an ibogaine bill in Mississippi.
- Ibogaine is being researched as a potential treatment for substance use disorder, depression, and PTSD.
- Addiction is framed as a health crisis, not a moral failing.
- Conventional treatments for opioid addiction have high relapse rates (65-70%).
- International clinics report high long-term recovery rates (50-70%) with ibogaine.
- Veterans are reportedly finding healing through ibogaine treatment abroad for PTSD.
- The need for more mental health treatment tools is presented as a bipartisan issue.
- Mississippi and the White House are publicly supporting the exploration of psychedelic therapies.